US20140162943A1 - N-terminus conformationally constrained glp-1 receptor agonist compounds - Google Patents

N-terminus conformationally constrained glp-1 receptor agonist compounds Download PDF

Info

Publication number
US20140162943A1
US20140162943A1 US14/165,705 US201414165705A US2014162943A1 US 20140162943 A1 US20140162943 A1 US 20140162943A1 US 201414165705 A US201414165705 A US 201414165705A US 2014162943 A1 US2014162943 A1 US 2014162943A1
Authority
US
United States
Prior art keywords
seq id
exendin
pro
compound
xaa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/165,705
Inventor
Josue Alfaro-Lopez
Abhinandini Sharma
Soumitra S. Ghosh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amylin Pharmaceuticals LLC
AstraZeneca Pharmaceuticals LP
Original Assignee
Amylin Pharmaceuticals LLC
AstraZeneca Pharmaceuticals LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US16560409P priority Critical
Priority to PCT/US2010/028883 priority patent/WO2010120476A2/en
Priority to US201113260702A priority
Application filed by Amylin Pharmaceuticals LLC, AstraZeneca Pharmaceuticals LP filed Critical Amylin Pharmaceuticals LLC
Priority to US14/165,705 priority patent/US20140162943A1/en
Publication of US20140162943A1 publication Critical patent/US20140162943A1/en
Application status is Abandoned legal-status Critical

Links